Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.jaip.2016.04.008

http://scihub22266oqcxt.onion/10.1016/j.jaip.2016.04.008
suck pdf from google scholar
C4939240!4939240 !27393772
unlimited free pdf from europmc27393772
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27393772 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid27393772
      J+Allergy+Clin+Immunol+Pract 2016 ; 4 (4 ): 584-9
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Infectious Chronic Rhinosinusitis #MMPMID27393772
  • Bose S ; Grammer LC ; Peters AT
  • J Allergy Clin Immunol Pract 2016[Jul]; 4 (4 ): 584-9 PMID27393772 show ga
  • Chronic rhinosinusitis (CRS) is a persistent inflammatory disease that affects a multitude of people worldwide. The pathogenesis of CRS involves many factors including genetics, status of the sinonasal microbiome, infections, and environmental influences. Comorbidities associated with CRS include asthma, allergic rhinitis, bronchiectasis, and certain kinds of immunodeficiency. CRS can be divided into different subtypes based on endotypes and phenotypes. Infectious CRS is one such category. The etiology of infectious CRS is usually secondary to chronic bacterial infection that commonly begins with a viral upper respiratory tract infection. Humoral antibody deficiencies can underlie difficult-to-treat or recurrent CRS. Infectious CRS can be treated with antimicrobials, topical or oral corticosteroids, and nasal saline irrigations. Patients with CRS and humoral immunodeficiency may require an aggressive treatment approach including immunoglobulin replacement therapy. Despite advancements in the field of CRS, targeted therapies and reliable biomarkers are still lacking.
  • |*Communicable Diseases/epidemiology/etiology/immunology/therapy [MESH]
  • |*Rhinitis/epidemiology/etiology/immunology/therapy [MESH]
  • |*Sinusitis/epidemiology/etiology/immunology/therapy [MESH]
  • |Biomarkers [MESH]
  • |Chronic Disease [MESH]
  • |Comorbidity [MESH]
  • |Humans [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box